nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Progesterone—uterine cancer	0.15	0.215	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.15	0.215	CbGbCtD
Lercanidipine—CYP3A5—Progesterone—uterine cancer	0.113	0.162	CbGbCtD
Lercanidipine—CYP2D6—Progesterone—uterine cancer	0.0691	0.0991	CbGbCtD
Lercanidipine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0663	0.0951	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—uterine cancer	0.0504	0.0723	CbGbCtD
Lercanidipine—CYP3A4—Progesterone—uterine cancer	0.0439	0.063	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—uterine cancer	0.0211	0.0303	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—uterine cancer	0.0197	0.0282	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—uterine cancer	0.0134	0.0192	CbGbCtD
Lercanidipine—Anaemia—Etoposide—uterine cancer	0.000391	0.00129	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00039	0.00129	CcSEcCtD
Lercanidipine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000389	0.00128	CcSEcCtD
Lercanidipine—Migraine—Epirubicin—uterine cancer	0.000387	0.00128	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000386	0.00127	CcSEcCtD
Lercanidipine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000385	0.00127	CcSEcCtD
Lercanidipine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000385	0.00127	CcSEcCtD
Lercanidipine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000383	0.00126	CcSEcCtD
Lercanidipine—Malaise—Etoposide—uterine cancer	0.000381	0.00126	CcSEcCtD
Lercanidipine—Face oedema—Epirubicin—uterine cancer	0.00038	0.00125	CcSEcCtD
Lercanidipine—Vertigo—Etoposide—uterine cancer	0.00038	0.00125	CcSEcCtD
Lercanidipine—Abdominal pain—Dactinomycin—uterine cancer	0.000377	0.00124	CcSEcCtD
Lercanidipine—Body temperature increased—Dactinomycin—uterine cancer	0.000377	0.00124	CcSEcCtD
Lercanidipine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000373	0.00123	CcSEcCtD
Lercanidipine—Cardiac failure—Doxorubicin—uterine cancer	0.000373	0.00123	CcSEcCtD
Lercanidipine—Loss of consciousness—Etoposide—uterine cancer	0.000372	0.00123	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000372	0.00123	CcSEcCtD
Lercanidipine—Cough—Etoposide—uterine cancer	0.000369	0.00122	CcSEcCtD
Lercanidipine—Blood creatinine increased—Epirubicin—uterine cancer	0.000369	0.00122	CcSEcCtD
Lercanidipine—Hyponatraemia—Doxorubicin—uterine cancer	0.000366	0.00121	CcSEcCtD
Lercanidipine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.0012	CcSEcCtD
Lercanidipine—Chest pain—Etoposide—uterine cancer	0.00036	0.00119	CcSEcCtD
Lercanidipine—Abdominal pain upper—Epirubicin—uterine cancer	0.000359	0.00119	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000359	0.00119	CcSEcCtD
Lercanidipine—Migraine—Doxorubicin—uterine cancer	0.000358	0.00118	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000357	0.00118	CcSEcCtD
Lercanidipine—Discomfort—Etoposide—uterine cancer	0.000356	0.00117	CcSEcCtD
Lercanidipine—Breast disorder—Epirubicin—uterine cancer	0.000356	0.00117	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000354	0.00117	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000354	0.00117	CcSEcCtD
Lercanidipine—Nasopharyngitis—Epirubicin—uterine cancer	0.000352	0.00116	CcSEcCtD
Lercanidipine—Face oedema—Doxorubicin—uterine cancer	0.000351	0.00116	CcSEcCtD
Lercanidipine—Hypersensitivity—Dactinomycin—uterine cancer	0.000351	0.00116	CcSEcCtD
Lercanidipine—Confusional state—Etoposide—uterine cancer	0.000348	0.00115	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000347	0.00114	CcSEcCtD
Lercanidipine—Muscular weakness—Epirubicin—uterine cancer	0.000347	0.00114	CcSEcCtD
Lercanidipine—Asthenia—Dactinomycin—uterine cancer	0.000342	0.00113	CcSEcCtD
Lercanidipine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000341	0.00112	CcSEcCtD
Lercanidipine—Asthma—Epirubicin—uterine cancer	0.00034	0.00112	CcSEcCtD
Lercanidipine—Thrombocytopenia—Etoposide—uterine cancer	0.000338	0.00111	CcSEcCtD
Lercanidipine—Tachycardia—Etoposide—uterine cancer	0.000337	0.00111	CcSEcCtD
Lercanidipine—Skin disorder—Etoposide—uterine cancer	0.000335	0.00111	CcSEcCtD
Lercanidipine—Hyperhidrosis—Etoposide—uterine cancer	0.000334	0.0011	CcSEcCtD
Lercanidipine—Pancreatitis—Epirubicin—uterine cancer	0.000333	0.0011	CcSEcCtD
Lercanidipine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000333	0.0011	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000333	0.0011	CcSEcCtD
Lercanidipine—Angina pectoris—Epirubicin—uterine cancer	0.000331	0.00109	CcSEcCtD
Lercanidipine—Breast disorder—Doxorubicin—uterine cancer	0.000329	0.00109	CcSEcCtD
Lercanidipine—Anorexia—Etoposide—uterine cancer	0.000329	0.00108	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000328	0.00108	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000328	0.00108	CcSEcCtD
Lercanidipine—Diarrhoea—Dactinomycin—uterine cancer	0.000326	0.00108	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000326	0.00107	CcSEcCtD
Lercanidipine—Pancytopenia—Epirubicin—uterine cancer	0.000323	0.00107	CcSEcCtD
Lercanidipine—Hypotension—Etoposide—uterine cancer	0.000322	0.00106	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000321	0.00106	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—uterine cancer	0.000321	0.00106	CcSEcCtD
Lercanidipine—Neutropenia—Epirubicin—uterine cancer	0.000318	0.00105	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—uterine cancer	0.000315	0.00104	CcSEcCtD
Lercanidipine—Pollakiuria—Epirubicin—uterine cancer	0.000314	0.00104	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00031	0.00102	CcSEcCtD
Lercanidipine—Paraesthesia—Etoposide—uterine cancer	0.00031	0.00102	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—uterine cancer	0.000309	0.00102	CcSEcCtD
Lercanidipine—Dyspnoea—Etoposide—uterine cancer	0.000308	0.00101	CcSEcCtD
Lercanidipine—Somnolence—Etoposide—uterine cancer	0.000307	0.00101	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—uterine cancer	0.000307	0.00101	CcSEcCtD
Lercanidipine—Vomiting—Dactinomycin—uterine cancer	0.000303	0.001	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000301	0.000992	CcSEcCtD
Lercanidipine—Rash—Dactinomycin—uterine cancer	0.000301	0.000991	CcSEcCtD
Lercanidipine—Decreased appetite—Etoposide—uterine cancer	0.0003	0.000989	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—uterine cancer	0.000299	0.000986	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—uterine cancer	0.000298	0.000983	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000298	0.000982	CcSEcCtD
Lercanidipine—Fatigue—Etoposide—uterine cancer	0.000297	0.000981	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000297	0.00098	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—uterine cancer	0.000296	0.000975	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—uterine cancer	0.000296	0.000975	CcSEcCtD
Lercanidipine—Constipation—Etoposide—uterine cancer	0.000295	0.000973	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—uterine cancer	0.000294	0.00097	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—uterine cancer	0.000291	0.000959	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000287	0.000947	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000287	0.000946	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—uterine cancer	0.000284	0.000938	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—uterine cancer	0.000283	0.000934	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—uterine cancer	0.000283	0.000933	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—uterine cancer	0.000282	0.000931	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000278	0.000917	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—uterine cancer	0.000276	0.00091	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000275	0.000907	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—uterine cancer	0.000274	0.000904	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—uterine cancer	0.000273	0.000902	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—uterine cancer	0.000273	0.000902	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—uterine cancer	0.000273	0.0009	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—uterine cancer	0.000273	0.0009	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—uterine cancer	0.000273	0.0009	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—uterine cancer	0.000272	0.000898	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—uterine cancer	0.000269	0.000887	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—uterine cancer	0.000268	0.000884	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—uterine cancer	0.000267	0.000882	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—uterine cancer	0.000267	0.00088	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000265	0.000875	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—uterine cancer	0.000262	0.000864	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—uterine cancer	0.000257	0.000849	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—uterine cancer	0.000254	0.000839	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—uterine cancer	0.000254	0.000838	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—uterine cancer	0.000254	0.000837	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—uterine cancer	0.000253	0.000833	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—uterine cancer	0.000253	0.000833	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—uterine cancer	0.000252	0.000833	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—uterine cancer	0.000252	0.000831	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000249	0.00082	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—uterine cancer	0.000248	0.000818	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—uterine cancer	0.000248	0.000816	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000247	0.000816	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—uterine cancer	0.000247	0.000815	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—uterine cancer	0.000247	0.000814	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—uterine cancer	0.000246	0.000811	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—uterine cancer	0.000245	0.000809	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—uterine cancer	0.000244	0.000805	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—uterine cancer	0.000241	0.000793	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—uterine cancer	0.000238	0.000787	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—uterine cancer	0.000238	0.000785	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—uterine cancer	0.000237	0.000782	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—uterine cancer	0.000237	0.000782	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—uterine cancer	0.000236	0.000779	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—uterine cancer	0.000235	0.000776	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—uterine cancer	0.000235	0.000775	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—uterine cancer	0.000234	0.000771	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—uterine cancer	0.000234	0.000771	CcSEcCtD
Lercanidipine—Tension—Epirubicin—uterine cancer	0.000233	0.000767	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—uterine cancer	0.000232	0.000765	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—uterine cancer	0.00023	0.000759	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—uterine cancer	0.000229	0.000754	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—uterine cancer	0.000228	0.000752	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—uterine cancer	0.000228	0.000751	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—uterine cancer	0.000227	0.00075	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000227	0.000749	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—uterine cancer	0.000223	0.000737	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—uterine cancer	0.000223	0.000734	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—uterine cancer	0.000221	0.000728	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—uterine cancer	0.00022	0.000725	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—uterine cancer	0.000219	0.000724	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—uterine cancer	0.000219	0.000723	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—uterine cancer	0.000219	0.000723	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—uterine cancer	0.000219	0.000722	CcSEcCtD
Lercanidipine—Rash—Etoposide—uterine cancer	0.000218	0.000717	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—uterine cancer	0.000217	0.000717	CcSEcCtD
Lercanidipine—Headache—Etoposide—uterine cancer	0.000216	0.000713	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—uterine cancer	0.000215	0.00071	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—uterine cancer	0.000215	0.000708	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—uterine cancer	0.000214	0.000705	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—uterine cancer	0.000213	0.000702	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—uterine cancer	0.000213	0.000702	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—uterine cancer	0.000212	0.000701	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—uterine cancer	0.000211	0.000695	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—uterine cancer	0.000209	0.000691	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—uterine cancer	0.000208	0.000687	CcSEcCtD
Lercanidipine—Cough—Epirubicin—uterine cancer	0.000207	0.000682	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—uterine cancer	0.000207	0.000682	CcSEcCtD
Lercanidipine—Nausea—Etoposide—uterine cancer	0.000205	0.000676	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000203	0.000671	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—uterine cancer	0.000203	0.000668	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—uterine cancer	0.000202	0.000665	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—uterine cancer	0.000202	0.000665	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—uterine cancer	0.000202	0.000665	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—uterine cancer	0.000201	0.000663	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.0002	0.000661	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—uterine cancer	0.000199	0.000657	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—uterine cancer	0.000198	0.000652	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—uterine cancer	0.000197	0.000651	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—uterine cancer	0.000197	0.00065	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—uterine cancer	0.000197	0.000649	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—uterine cancer	0.000195	0.000643	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—uterine cancer	0.000194	0.000639	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—uterine cancer	0.000193	0.000636	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—uterine cancer	0.000191	0.000631	CcSEcCtD
Lercanidipine—Shock—Epirubicin—uterine cancer	0.00019	0.000628	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—uterine cancer	0.00019	0.000626	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—uterine cancer	0.000189	0.000625	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—uterine cancer	0.000189	0.000623	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—uterine cancer	0.000188	0.00062	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—uterine cancer	0.000187	0.000617	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—uterine cancer	0.000187	0.000616	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—uterine cancer	0.000187	0.000616	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—uterine cancer	0.000187	0.000616	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—uterine cancer	0.000186	0.000614	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000185	0.000611	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—uterine cancer	0.000184	0.000608	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—uterine cancer	0.000184	0.000608	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—uterine cancer	0.000183	0.000602	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—uterine cancer	0.000181	0.000596	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—uterine cancer	0.00018	0.000595	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000176	0.000581	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—uterine cancer	0.000176	0.000581	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—uterine cancer	0.000175	0.000579	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000175	0.000578	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—uterine cancer	0.000175	0.000577	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—uterine cancer	0.000175	0.000576	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—uterine cancer	0.000174	0.000573	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—uterine cancer	0.000174	0.000573	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000173	0.000571	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—uterine cancer	0.000172	0.000569	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—uterine cancer	0.000172	0.000567	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—uterine cancer	0.000171	0.000563	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—uterine cancer	0.00017	0.000561	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—uterine cancer	0.000168	0.000554	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—uterine cancer	0.000167	0.000551	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000167	0.000551	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—uterine cancer	0.000167	0.00055	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—uterine cancer	0.000165	0.000545	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000163	0.000538	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—uterine cancer	0.000162	0.000534	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—uterine cancer	0.000161	0.00053	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—uterine cancer	0.00016	0.000526	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—uterine cancer	0.000159	0.000526	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—uterine cancer	0.000159	0.000525	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000158	0.000522	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—uterine cancer	0.000158	0.00052	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—uterine cancer	0.000156	0.000513	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000154	0.00051	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—uterine cancer	0.000154	0.000509	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—uterine cancer	0.000154	0.000507	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—uterine cancer	0.000153	0.000505	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—uterine cancer	0.000153	0.000504	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—uterine cancer	0.000153	0.000504	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—uterine cancer	0.000147	0.000486	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000146	0.000483	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—uterine cancer	0.000142	0.00047	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—uterine cancer	0.000142	0.000469	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—uterine cancer	0.000141	0.000467	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—uterine cancer	0.000141	0.000467	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—uterine cancer	0.000139	0.000458	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—uterine cancer	0.000137	0.000451	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—uterine cancer	0.000132	0.000436	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—uterine cancer	0.000132	0.000435	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—uterine cancer	0.000128	0.000423	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—uterine cancer	0.000128	0.000422	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—uterine cancer	0.000127	0.000418	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—uterine cancer	0.000123	0.000406	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—uterine cancer	0.000122	0.000404	CcSEcCtD
Lercanidipine—Rash—Epirubicin—uterine cancer	0.000122	0.000402	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—uterine cancer	0.000122	0.000402	CcSEcCtD
Lercanidipine—Headache—Epirubicin—uterine cancer	0.000121	0.0004	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—uterine cancer	0.000118	0.00039	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—uterine cancer	0.000115	0.000379	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—uterine cancer	0.000114	0.000375	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—uterine cancer	0.000113	0.000372	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—uterine cancer	0.000113	0.000372	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—uterine cancer	0.000112	0.00037	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—uterine cancer	0.000106	0.000351	CcSEcCtD
